Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 1
2000 2
2001 3
2002 3
2003 4
2004 1
2005 3
2006 1
2007 1
2008 2
2009 2
2010 4
2011 2
2012 9
2013 12
2014 9
2015 12
2016 14
2017 9
2018 17
2019 7
2020 11
2021 9
2022 8
2023 11
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year

Filters applied: . Clear all
The following term was ignored: %
The following term was not found in PubMed: 20Lapierre
Page 1
Interventions for preventing and treating incontinence-associated dermatitis in adults.
Beeckman D, Van Damme N, Schoonhoven L, Van Lancker A, Kottner J, Beele H, Gray M, Woodward S, Fader M, Van den Bussche K, Van Hecke A, De Meyer D, Verhaeghe S. Beeckman D, et al. Cochrane Database Syst Rev. 2016 Nov 10;11(11):CD011627. doi: 10.1002/14651858.CD011627.pub2. Cochrane Database Syst Rev. 2016. PMID: 27841440 Free PMC article. Review.
Reply to Lisette et al.
Grabias B, Essuman E, Oakley M, Kumar S. Grabias B, et al. J Infect Dis. 2018 Mar 5;217(6):1012-1013. doi: 10.1093/infdis/jix673. J Infect Dis. 2018. PMID: 29309646 No abstract available.
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.
Karasik A, Lanzinger S, Chia-Hui Tan E, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Ha KH, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K, Nyström T, Niskanen L, Linnemann Jensen M, Hoti F, Klement R, Déruaz-Luyet A, Kyaw MH, Koeneman L, Vistisen D, Carstensen B, Halvorsen S, Langslet G, Fazeli Farsani S, Patorno E, Núñez J; EMPRISE Europe and Asia Study Group. Karasik A, et al. Diabetes Metab. 2023 Mar;49(2):101418. doi: 10.1016/j.diabet.2022.101418. Epub 2023 Jan 3. Diabetes Metab. 2023. PMID: 36608816 Free article.
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
Vernooij LM, van Klei WA, Moons KG, Takada T, van Waes J, Damen JA. Vernooij LM, et al. Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2. Cochrane Database Syst Rev. 2021. PMID: 34931303 Free PMC article. Review.
Interventions for impetigo.
Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LW, Morris AD, Butler CC, Berger M, van der Wouden JC. Koning S, et al. Cochrane Database Syst Rev. 2012 Jan 18;1(1):CD003261. doi: 10.1002/14651858.CD003261.pub3. Cochrane Database Syst Rev. 2012. PMID: 22258953 Free PMC article. Review.
Discovering resilience.
Curnow L. Curnow L. J Genet Couns. 2012 Apr;21(2):183-4. doi: 10.1007/s10897-011-9441-2. Epub 2011 Dec 8. J Genet Couns. 2012. PMID: 22160498 No abstract available.
Osteoporosis in chronic obstructive pulmonary disease.
Romme EA, Smeenk FW, Rutten EP, Wouters EF. Romme EA, et al. Expert Rev Respir Med. 2013 Aug;7(4):397-410. doi: 10.1586/17476348.2013.814402. Epub 2013 Aug 16. Expert Rev Respir Med. 2013. PMID: 23952337 Review.
154 results